Taiwanese company JHL Biotech will stop developing biosimilar versions of Genentech’s drugs as part of a memorandum of understanding signed by the parties to end trade secrets litigation.
Indian drugmaker Lupin and German pharma company Boehringer Ingelheim have formed an alliance to develop a therapy for patients with difficult-to-treat cancers.
Hong Kong customs authorities have carried out a series of raids resulting in the seizure of counterfeit vaccines worth over HKD $1 million, some containing poison.
PepsiCo India is withdrawing its lawsuits against nine farmers in the Gujarat region who it accused of growing a protected variety of potato used to make the company’s ‘Lay’s’ brand of crisps.
PepsiCo India is attempting to settle a lawsuit against four Indian farmers who the food and drink company say infringed its IP by growing a protected variety of potato.
Duane Morris & Selvam has strengthened its IP practice with the addition of John Alison from Winston & Strawn.
World Health Organization (WHO) experts have called for central registry on human genome editing research is needed, among a committee consensus that it would be irresponsible for any scientist to conduct gene-editing studies in people.
Israel-based Teva has predicted 2019 will be a tough year, with lower revenue and profit, as the company faces generic competition for two of its top-selling drugs.
The lobby group for India’s pharma industry has asked the US Trade Representative office to remove India from its Priority Watch List of places that have weak enforcement of intellectual property laws.
A US district court has sentenced a Chinese national to 27 months in federal prison for the theft of trade secrets from two American medical device manufacturers.